浙商机械 邱世梁|王华君 人形机器人系列【福莱新材】电子皮肤性能与交付领先，持续推荐-2026/2/2 1、主业稳健：国内喷墨打印复合材料行业首家实现基膜、胶水、涂布一体化的企业 2、电子皮肤：好赛道！稀缺价值量有扩张逻辑的人机零部件，具身智能落地的最后一公里 3、公司性能与交付领先 1、主业稳健：国内喷墨打印复合材料行业首家实现基膜、胶水、涂布一体化的企业 2、电子皮肤：好赛道！稀缺价值量有扩张逻辑的人机零部件，具身智能落地的最后一公里 3、公司性能与交付领先 1）技术突破：公司合作# 清华柔电院 # 通智科技 ，形成"材料+芯片+算法"的全栈式技术能力，分别于2025年2 月、6月、11月举办新品发布会相继推出三代柔性触觉传感器产品，其中第三代产品实现芯感一体，可在指尖完成 边缘计算 2）商业化进展：2025年12月，公司向灵心巧手交付千套级电子皮肤，目前已与国内外几十家客户合作，除机器人 之外，在工业检测、新能源、消费电子等场景也有应用 风险提示：柔性触觉传感器发展不及预期 3）北美实现小批量订单：公司已成立北美子公司，现北美销售负责人为前Syntouch公司副总裁 1）技术突破：公司合作# 清华柔电院 ...

Core Viewpoint - The article emphasizes the investment value of significant events, industry chain companies, and key policy interpretations, providing timely market impact references through a professional lens [1] Group 1: Product and Market Insights - The company has begun small-scale supply of electronic skin products, focusing on flexible tactile sensors, electronic noses, and inertial measurement units for embodied intelligent products [1] - The company holds the leading market share in the domestic sensor segment for several years [1] - The company has established connections and collaborations with nearly 30 robot manufacturers and component suppliers [1]

Core Viewpoint - The humanoid robot market, particularly the dexterous hand component, is experiencing a surge in investment and development, with Chinese companies strategically positioned to capitalize on this growth by 2025 [1][3][23] Investment Trends - Since 2024, there have been over 20 financing rounds related to dexterous hands in China, accumulating more than 3 billion yuan [1] - In April 2025, Lingxin Dexterous Hand secured over 100 million yuan in seed funding, setting a record for the industry [3] - By December 2025, Lingxin Dexterous Hand successfully completed an A++ round of financing with major investors like Sequoia China [3] Market Position and Production Goals - Lingxin Dexterous Hand currently holds over 80% of the global market for high-freedom dexterous hands and plans to deliver between 50,000 to 100,000 units in 2026 [3] - Certain companies have achieved mass production of dexterous hands, with one aiming for a production increase of over 50 times by 2026 [8] Policy Support - The Chinese government has prioritized "intelligent dexterous hands" as a core technology for breakthrough, with plans to establish industry standards by the end of 2025 [5] - Local governments are actively promoting the dexterous hand industry, with initiatives in Shanghai and Shandong to enhance technological development [5][7] Industry Dynamics - The most profitable segment of the dexterous hand industry lies in the upstream core components, such as hollow cup motors and flexible tactile sensors, with significant market sizes projected for 2025 [10] - Companies are forming strategic partnerships to integrate their supply chains, exemplified by a 300 million yuan collaboration between Aoyi Technology and a major automotive parts manufacturer [14] Challenges Ahead - Despite the current excitement, the dexterous hand industry faces challenges such as high costs, lack of unified technology standards, and a shortage of skilled talent [16][18] - The industry must overcome these hurdles to achieve large-scale commercialization and widespread adoption [18] Future Applications - The potential applications of dexterous hands extend beyond humanoid robots to include precision assembly in industrial manufacturing, surgical assistance in healthcare, and operations in high-risk environments [20][21] - As technology matures, dexterous hands are expected to become independent intelligent modules, enhancing human-machine collaboration across various sectors [21][23]

据智通财经12月19日讯，据国家药监局消息，12月18日，国家药监局在北京召开脑机接口医疗器械工作 推进会。会议听取高等院校、科研院所、医疗机构相关专家学者和研发企业代表意见建议。国家药监局 党组成员、副局长雷平出席会议并讲话。 会议要求，要深入贯彻落实党的二十届四中全会精神，深刻领会脑机接口作为前瞻布局未来产业的重要 战略意义；要坚持安全有效为首要前提，创新审评监管方法，构建标准体系，加强技术指导服务；要加 强跨部门合作，联手产学研医各方，合力解决关键技术问题，完善产业链供应链；要落实企业主体责 任，以问题为导向，提升产品可靠性和整体竞争力，积极推动脑机接口器械更快更好服务临床、惠及患 者。 国家药监局器械注册司、标管中心、器审中心负责同志及有关人员参加会议。 相关市场板块分析 医疗器械与康复设备：脑机接口技术率先在医疗康复领域落地，多家公司产品进入临床试验阶段，相关 医疗器械企业迎来技术升级与需求扩张，市场潜力巨大。 人工智能与大数据：脑机接口依赖高精度算法与海量数据处理，AI企业在脑电信号解码、情绪识别、 脑电大模型等领域深度布局，推动技术迭代。 消费电子与智能穿戴：非侵入式脑机接口在游戏、教育、疲劳监 ...

Core Viewpoint - Hanwei Technology is strategically investing in Chongqing Stabao Technology Co., Ltd. to enhance its capabilities in high-end temperature sensors, aiming to break the long-standing foreign monopoly in this field [1][2] Investment and Expansion - Hanwei Technology plans to invest nearly 28 million yuan of its own funds in Chongqing Stabao, which has developed various models of thin-film platinum resistance temperature sensors that meet international advanced technology standards [1] - The company is also planning to issue H-shares and apply for listing on the Hong Kong Stock Exchange to accelerate overseas business development and enhance its international brand recognition [1] Product Development and Market Position - Hanwei Technology holds a 70% market share in domestic gas sensor products, establishing itself as a leader in the sensor industry, with many products filling domestic gaps [2] - The company has developed over 300 types of sensors across 17 series, including semiconductor, catalytic combustion, electrochemical, infrared, and more, positioning itself to capitalize on trends in AI and robotics [2] Sensor Technology and Applications - The company has created a multi-dimensional sensor matrix covering smell, touch, balance, force control, and vision for robotics, enhancing the capabilities of intelligent robots [4][5] - Hanwei's electronic nose can detect various gases for environmental safety monitoring, while flexible tactile sensors enable real-time force perception for human-robot interaction [4][5] Future Prospects and Industry Trends - The domestic sensor industry is expected to grow significantly, with increasing localization rates presenting substantial market opportunities [6] - Hanwei Technology is committed to enhancing its R&D investments to maintain its technological edge, despite potential short-term impacts on financial performance from new business ventures [6] - The market for humanoid robots is projected to reach a scale of 10 trillion yuan, with electronic skin as a core component, indicating strong growth potential for Hanwei's products [6]

Core Insights - The humanoid robot industry is entering the commercialization phase, with "humanoid tactile interaction" identified as a key bottleneck for application expansion. Flexible tactile sensors, referred to as "electronic skin," are crucial for providing robots with multi-modal perception capabilities, forming the foundational sensory network for interaction with the physical world. By 2030, the demand for flexible tactile sensors is projected to reach 1.525 million square meters, with a market size of 27.4 billion yuan [1][3]. Company Overview - Fulei New Materials, established in 2009 and listed on the Shanghai Stock Exchange in April 2021, focuses on the research, production, and sales of functional coated composite materials. The company has been developing flexible sensors since 2017, launching its first tactile sensor in February and a second-generation product in June, which can detect force vectors in three directions [3][4]. Product Development - Fulei New Materials introduced a new generation tactile sensing system that integrates flexible materials, chips, algorithms, and large models. The system features three core technological breakthroughs: "chip-sensor integration," advanced intelligent algorithms for enhanced object interaction, and an expanded effective sensing area to improve tactile information acquisition [1][4]. Market Positioning - The company has established partnerships with numerous domestic and international clients, with some expressing demand for over a hundred units. In the North American market, clients prioritize product consistency, reliability, lifespan, and signal drift, which are critical for providing reliable data to robotic systems. Fulei New Materials has a competitive edge in supply chain efficiency and has set up a wholly-owned subsidiary in California to facilitate bulk supply [4][5]. Financial Strategy - Fulei New Materials is progressing with its refinancing project, planning to raise up to 707 million yuan through a private placement. The funds will be allocated to expand production capacity for label printing materials, upgrade electronic-grade functional materials, enhance the research center, and supplement working capital. The company aims to transition from a supplier of coated materials to a new materials innovator and comprehensive solution provider [5].

Investment Rating - The report maintains an investment rating of "B" for the electronic skin industry, indicating a leading position in the market [1]. Core Insights - The electronic skin is a key tactile sensing system for humanoid robots, enabling them to interact with their environment through pressure and temperature sensing [13]. - The market for electronic skin is projected to reach $756 million by 2030, driven by the increasing demand for humanoid robots [4]. - The industry faces three major barriers: materials, manufacturing processes, and algorithms, which are critical for establishing competitive advantages [24][32]. Summary by Sections 1. Electronic Skin: Key to Humanoid Robot Interaction - Electronic skin mimics natural skin functions and is essential for humanoid robots to perceive their surroundings [13]. - The technology can be categorized into resistive, capacitive, and piezoelectric types, with resistive sensors being the most common in humanoid robots [2][21]. 2. Domestic Enterprises Accelerating Layout - Overseas companies dominate the high-end market, holding approximately 57.1% of the global flexible tactile sensor market share [4][41]. - Domestic companies are rapidly closing the technology gap, supported by favorable policies and manufacturing capabilities, with firms like Fulei New Materials and Hanwei Technology emerging as key players [5][46]. 3. Key Companies to Watch - Fulei New Materials has completed pilot production and is supplying small batches to leading clients in the dexterous hand sector [5]. - Hanwei Technology has established partnerships with nearly 30 robot manufacturers and is expanding its production capacity [5]. - Keli Sensor and other companies are also making strides in the electronic skin sector, focusing on multi-physical sensors and flexible tactile sensors [5][46].

Core Insights - A significant news event has emerged regarding Yushu Technology, a prominent player in humanoid robotics, which has completed its IPO guidance, indicating a potential listing on the STAR Market in the first quarter of next year [1][2][3] Financial Performance - Yushu Technology's financial performance shows a remarkable net profit of 589 million yuan for the third quarter, reflecting a staggering year-on-year growth of 469.1% [2][5] - The total revenue for Yushu Technology reached 14.454 billion yuan, with a year-on-year decline of 8.8% [2] - Liou Co., a financial investor in Yushu Technology, reported a net profit of 589 million yuan, marking a turnaround from a loss [5] - Jinfa Technology achieved a net profit of 1.065 billion yuan, with a year-on-year growth of 55.86% [6][7] - Zhongke Chuangda reported a net profit of 229 million yuan, reflecting a growth of 50.72% [8][11] Market Dynamics - The recent acceleration in listings of hard technology companies, including Yushu Technology, is seen as a strategic move to inject confidence into the market [3] - Companies closely associated with Yushu Technology, referred to as "shadow stocks," are expected to benefit significantly from its upcoming IPO [4][9] Supply Chain Relationships - Yushu Technology has established strong ties with key suppliers, including Zhongda Lide, Mingzhi Electric, and Aobi Zhongguang, which provide essential components for its robotics [9] - The dual role of companies like Zhongke Chuangda and Allwinner Technology, which both invest in and supply Yushu Technology, enhances their strategic partnership [9][11]

Core Viewpoint - Yushu Technology Co., Ltd. plans to submit its IPO application in Q4 2025, marking a significant milestone as the first profitable humanoid robot company globally, which is expected to attract attention to the entire humanoid robot industry chain [1] Shareholding/Investment - Juxing Technology holds shares in Yushu Technology through its subsidiary, ensuring clear equity investment and direct asset appreciation [3] - Jing Shan Light Machine participated in Yushu's early investment through an industrial investment fund, though specific shareholding ratios are not disclosed [3] - Shoukai Co., Ltd. indirectly holds approximately 0.85% of shares through the Jinshi Growth Fund, indicating a relatively high indirect shareholding among A-share listed companies [3] - Jinfat Technology holds 4.77% indirectly through the Jinshi Growth Fund and is a leading chemical materials company with over 60% market share in robot shell materials, reporting a 35.5% revenue growth in H1 2025 [3] - Wolong Electric Drive holds 0.1525% indirectly and has seen a 36.76% net profit increase in H1 2025, with a gross margin of 28% [3] - Other companies like Jingxing Paper and Rongsheng Environmental Protection hold minor indirect stakes, primarily for financial investment [3][4] Core Suppliers - Zhongdali De is the core supplier of planetary reducers, with orders locked at 3.2 billion yuan for 2025, accounting for 36% of Yushu's costs [6] - Changsheng Bearings exclusively supplies self-lubricating bearings with over 80% penetration, expecting 8% of its revenue from robot business in 2025 [6] - Aobi Zhongguang is the sole supplier of 3D vision modules, with a supply ratio of 72% and a doubling of revenue in H1 2025 [6] - Lide Technology provides flexible tactile sensors, breaking the monopoly of Korean companies [6] - Weilan Lithium Core is the core supplier of lithium batteries for Yushu, with an expected 60% supply ratio in 2024 [6] Technical Cooperation Partners - iFLYTEK collaborates on developing the "robot brain," with a leading position in voice recognition and a planned R&D investment of 2.392 billion yuan in 2025 [8] - Lingyun Optical is jointly developing the FZMotion motion capture system, achieving high precision and expected stock price growth of over 200% in 2025 [8] - Zhongke Chuangda provides motion control algorithms and holds 1.86% of shares, with strong adaptability in edge computing modules [8] - Other partners include Shuanglin Co., Ltd. and Shengtong Co., Ltd., focusing on various components and educational collaborations in robotics [8][9]

Industry Background - The brain-computer interface (BCI) industry is entering a commercialization phase in 2025, driven by policy support and technological breakthroughs. The Ministry of Industry and Information Technology (MIIT) and other departments have set a goal for key technological breakthroughs by 2027 and the establishment of an industrial system [1] - The National Medical Insurance Administration has added pricing items for BCI implantation and adaptation fees, accelerating clinical applications and charging [1] - Domestic companies are making significant progress, with Shanghai Ladder Medical's implantable wireless BCI system becoming the first to enter the NMPA's green channel for innovative medical devices [1] - Global competition includes Neuralink's plan to launch a Telepathy device by 2029, but domestic companies have achieved technological advantages in certain areas, such as Yanshan Technology's 60ms ultra-low latency control performance [1] Industry Chain Overview - The BCI industry chain consists of three main segments: upstream (electrodes/chips), midstream (EEG processing devices), and downstream (application scenarios), each with distinct technological barriers and commercialization rhythms [3] - Upstream components, particularly implantable and non-invasive electrodes/chips, are critical for signal precision and stability, representing the core competitiveness of the industry [3] Upstream Segment - Implantable electrodes/chips are essential for medical applications, with companies like Gaode Infrared developing flexible tactile sensors that reduce immune rejection and extend signal collection duration [4] - Weisi Medical focuses on optimizing biocompatibility for its microelectrode arrays, which have entered clinical validation for precise localization in epilepsy [4] - Non-invasive chips serve as entry points for consumer applications, with companies like Xiangyu Medical developing multi-modal EEG acquisition devices for rehabilitation [7] Midstream Segment - The midstream segment is responsible for EEG signal acquisition, analysis, and transmission, with a focus on low latency (under 60ms) and multi-modal integration [9] - Companies like iFlytek have achieved a 92% accuracy rate in emotion recognition from EEG signals, indicating significant algorithmic advantages [10] - Yanshan Technology has achieved ultra-low latency control performance, surpassing early versions of Neuralink [11] Downstream Segment - The downstream applications are driven by both medical and consumer sectors, with a focus on epilepsy, Parkinson's disease, and gaming [13] - Medical rehabilitation is a high-demand area supported by policies, with companies like Aipeng Medical developing EEG acquisition devices and achieving a net profit margin of approximately 15% [14] - Consumer applications include gaming and smart home technologies, with companies like Tom Cat integrating BCI into AI games to develop mind-control products [16]